Zinc Oxide Nanoparticles Induce an Adverse Effect on Blood Glucose Levels Depending On the Dose and Route of Administration in Healthy and Diabetic Rats

Zinc Oxide Nanoparticles Induce an Adverse Effect on Blood Glucose Levels Depending On the Dose and Route of Administration in Healthy and Diabetic Rats

Different studies in experimental diabetes models suggest that zinc oxide nanoparticles (ZnONPs) are useful as antidiabetic agents. However, this evidence was performed and measured in long-term treatments and with repeated doses of ZnONPs. This work aimed to evaluate the ZnONPs acute effects on gly...

Full description

Bibliographic Details
Main Authors: Adolfo Virgen-Ortiz, Alejandro Apolinar-Iribe, Irene Díaz-Reval, Hortensia Parra-Delgado, Saraí Limón-Miranda, Enrique Alejandro Sánchez-Pastor, Luis Castro-Sánchez, Santos Jesús Castillo, Adan Dagnino-Acosta, Edgar Bonales-Alatorre, Alejandrina Rodríguez-Hernández
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Nanomaterials
Subjects:
zinc oxide nanoparticles
diabetes
hyperglycemic response
zinc
nanomedicine
nanoparticle toxicology
Online Access:https://www.mdpi.com/2079-4991/10/10/2005

Internet

https://www.mdpi.com/2079-4991/10/10/2005

Similar Items